DIO TREE Israeli Company
Dio Tree develops a novel small molecule for the treatment of ovarian cancer. The technology is based on inhibition of the enzyme DIO3, which is a major driver in many types of cancer, specifically ovarian cancer. The technology involves a series of small molecules targeting DIO3.
Health Tech & Life Sciences
Health Diagnostics
Medical
Pharmaceutical
Wellness
Alternatives
No alternatives listed yet.
Suggest an Alternative
Parent Companies/Investors
Office Locations
Nazareth, Israel
References
[1]
finder.startupnationcentral.org
- https://finder.startupnationcentral.org/company_page/dio-tree
[2]
crunchbase.com
- https://www.crunchbase.com/organization/dio-tree
External links are provided for reference and verification purposes.